CYTOTOXIC EFFECT OF CORCHORUS DEPRESSUS AGAINST HEPG2 AND HLE HUMAN LIVER CANCER CELLS by H Kakrani, Purvi et al.
Vol 11, Issue 12, 2018
Online - 2455-3891 
Print - 0974-2441
CYTOTOXIC EFFECT OF CORCHORUS DEPRESSUS AGAINST HEPG2 AND HLE HUMAN LIVER 
CANCER CELLS
PURVI H KAKRANI1, HARISH N KAKRANI1, MANAN RAVAL2*
1Department of Pharmacognosy, Shivam Pharmaceutical Studies and Research Center, Anand, Gujarat, India. 2Department of Pharmacognosy, 
Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Charusat Campus, Anand, Gujarat, India. 
Email: mananraval.ph@charusat.ac.in
Received: 14 June 2018, Revised and Accepted: 27 July 2018
ABSTRACT
Objective: The present study was designed to examine the cytotoxic effects of methanolic extract of aerial parts of Corchorus depressus and hexane, 
chloroform, ethyl acetate, and aqueous fractions of the same extract in the human hepatocellular carcinoma (HCC) (HepG2) and invasive hepatocellular 
carcinoma cell lines (HLE).
Methods: Anti-proliferative effects were evaluated using 3-(4,5-dimethythiazol2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and neutral red uptake 
(NRU) assay. Human HCC (HepG2) and invasive hepatocellular carcinoma cell lines (HLE) were treated with different concentrations of methanolic 
extract (10, 25, 50, 100, 200, 300, 400, and 500 µg/mL) of aerial parts of C. depressus as well as hexane, chloroform, ethyl acetate, and aqueous 
fractions (200 µg/mL) for 24 and 48 h. The cell viability and the half maximal inhibitory concentration (IC50) were determined.
Results: The maximum cytotoxic effect was noticed with a maximum dose of methanolic extract (500 µg/mL) and alkaloidal fraction (200 µg) in this 
study with an IC50 value of about 200 µg.
Conclusion: The set of studies showed that methanolic extract of aerial parts of C. depressus and alkaloidal, chloroform and ethyl acetate fractions 
fractions was capable of inhibiting cell growth and cell proliferation by inducing cytotoxicity of HepG2 and HLE cells.
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INTRODUCTION
Hepatocellular carcinoma (liver cancer; HCC) is the fifth most common 
cancer worldwide now and causes significant public health problems, 
especially in association with chronic hepatitis B or C [1]. The liver 
functions to absorb and store nutrients, remove toxic waste and create 
clotting factors that stop bleeding from injuries. When HCC is present, 
the body exhibits symptoms such as drastic loss of weight, swelling 
in the abdomen, or jaundice [2]. The risk of developing liver cancer 
increases with factors associated with hepatitis B/C virus, aflatoxin, 
iron storage disease, cirrhosis, alcoholism, or obesity [3-5]. The average 
survival rate for hepatic cancer patients is 3–5% [6].
Corchorus depressus (Family Tiliaceae) (Cd) has been used in the 
indigenous system of medicine as a tonic, cooling medicine in fevers; 
its mucilage is prescribed in gonorrhea. Root is rubbed on stone and 
smeared over the forehead to get relief in migraine [7]. It is also used 
to increase the viscosity of the seminal fluid, to set-up menstrual 
disorder [8]. An extract of the plant is applied as a paste in the healing of 
wounds [9]. It has been used as antibacterial, antifungal, anthelmintic 
drug in folklore medicine [10], as antimalarial [11], has cardiotonic 
activity [12], as tonic [13], in the treatment of gonorrhea [14], as 
veterinary medicine [15] and possesses diuretic activity [16]. The plant 
is sweetish hot sharp acrid; removes tumors and pain; cures piles. It 
is given as a cooling medicine in fevers. The leaves are emollient. The 
seeds in decoction with milk and sugar are given as a tonic in Mahal 
Kohistan (Khirthar National Park) Pakistan [17].
C. depressus is reported to contain sitosterol, sitosterol glucoside, 
apigenin, luteolin, oleanolic acid, cordepressic acid, cordepressin, 
cordepressinic acid, α amyrin, kaempferol, etc., [18,19].
Lack of scientific data regarding antitumor properties of C. depressus (L.) 
prompted us to evaluate the claimed medicinal action.
Hepatic cancer is traditionally difficult to treat. Hence, the objectives of 
the current study were to (1) determine the in vitro cytotoxicity of Cd 
methanolic extract of aerial parts and its hexane, alkaloidal, chloroform, 
ethyl acetate and aqueous fractions, and aqueous fractions on HepG2 
and HLE cancer cells and (2) determine the cytotoxicity of actinomycin, 
an FDA-approved drug, for various cancers, against HCC.
In light of some reports [20,21], it is reasonable to assume that this plant 
could have anticancer potential. Hence, in this study, we investigated 
the cytotoxic potential of Cd methanolic extract of aerial parts and its 
hexane, alkaloidal, chloroform, ethyl acetate and aqueous fractions, and 
aqueous fractions against human Hep G2 and HLE cancer cell lines.
METHODS
Authentication of plant material
The fully grown plants of Cd were collected from Adipur region of 
Kachchh district in the month of September. Their authentication was 
confirmed by Dr. Suman Chandra Sharma, Taxonomist, Department of 
Botany, Government Dungar College, Bikaner, Rajasthan, and its voucher 
specimen deposited this plant with the Department of Pharmacognosy, 
Ramanbhai Patel College of pharmacy, Changa (CHARUSAT).
Cell culture
The Hep G2 and HLE cells were cultured in Dulbecco’s Modified 
Eagle medium supplemented with 10% of fetal bovine serum and 1% 
penicillin-streptomycin. Cell cultures were maintained at 37°C in a fully 
humidified atmosphere containing 5% CO2.
Cell treatment
Cd dried aerial parts methanolic extract; hexane, alkaloidal, chloroform, 
ethyl acetate and aqueous fractions were dissolved in 0.1% dimethyl 
sulfoxide (DMSO) (v/v). HepG2 and HLE cells were plated at 1.2 × 104 cells/
cm2. 24 h later, cells were fed with fresh expansion culture medium 
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supplemented with different final concentrations of extract (10, 25, 50, 
100, 200, 300, 400, and 500 µg/mL) or the corresponding volumes of the 
vehicle. After 24 h of treatment cells were collected after 0.05% trypsin 
application. Cell viability was also evaluated by 3-(4,5-dimethylthiazol-2-
yl)-2,5- diphenyltetrazoliumbromide (MTT) and neutral red uptake (NRU) 
assay [22].
MTT assay
According to the method described by Borenfreund et al. [23], the 
growth of cancer cells was quantified. Following a 24 h exposure period 
of drugs, cells were washed twice with phosphate buffered saline (PBS), 
and a 10 µL of MTT reagent (5 mg/mL in PBS) was added to each well 
including the blanks, which contained medium only. The plates were 
returned to the incubator for 4 h at 37°C. Subsequently, cells were 
washed twice with PBS, and 100 µL/well DMSO was added in each well 
as a solvent to dissolve the insoluble crystalline formazan products. The 
effect of plant extracts on cancer cells was quantified as the percentage 
of control absorbance of reduced dye at 550 nm on a microplate reader. 
For each treatment, five replicate wells were examined, and each 
experiment was repeated 3 times (n=3). Mean and standard deviation 
was calculated between three experiments. Results were calculated as 
percentage growth inhibition, untreated (control) cells versus treated 
cells according to the following formula:
Absorbance of positive control –  








 Positive control = absorbance of untreated cells after subtracting 
absorbance of media
 Absorbance of test sample = absorbance of treated cells at a particular 
concentration of testing sample after subtracting the absorbance of 
media.
The MTT cell proliferation assay measures the cell proliferation rate 
and conversely when metabolic events lead to apoptosis or necrosis, 
the reduction in cell viability. The number of assay steps has been 
minimized as much as possible to expedite sample processing. The MTT 
reagent yields low background absorbance values in the absence of 
cells. For each cell type, the linear relationship between cell number and 
signal produced is established, thus allowing accurate quantification of 
changes in the rate of cell proliferation [24].
NRU assay
The NRU assay was performed by removal of the medium after dosing 
cells, and 200 µL of neutral red solution (40 µg/mL) was added to 
each well (including the blanks, which contained medium only). After 
incubation for 2.5 h, the neutral red was removed, cells were carefully 
rinsed with pre-warmed PBS, and 200 µL of ethanol/acetic acid (1% 
glacial acetic acid in 5% ethanol) was added to all wells.
The plates were covered in foil and placed on a plate shaker for 30 min 
to extract neutral red from the cells and form a homogeneous solution. 
The absorbance of the wells was measured at 540 nm in a microplate 
reader within 60 min.
Cytotoxicity assays are widely used in toxicology studies. The NRU 
and 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide 
(MTT) assays are commonly used cytotoxicity assays to determine 
the cytotoxic properties of compounds. NRU assay has been used as 
an indicator of cytotoxicity in cultures of primary hepatocytes [25] 
and other cell lines [26]. Living cells take up the neutral red, which 
is concentrated within the lysosomes of cells [27]. MTT, a water-
soluble tetrazolium salt, is converted to insoluble purple formazan by 
cleavage of the tetrazolium ring by succinate dehydrogenase within 
the mitochondria. It is then solubilized in DMSO, and the cell viability 
depicts from its absorbance values [28].
Statistical analysis
In both the in vitro tests, statistical analysis was done by Dunnett’s 




Cd methanolic extract caused dose-dependent increase in cytotoxicity in 
HepG2 and HLE human liver cancer cells. The maximum cytotoxic effect 
was noticed with the maximum dose used in this study, i.e., 500 µg/mL 
(Fig. 1). The extract showed an inhibitory concentration (IC50) is about 200 
µg (Fig. 1). The anti-proliferative activity was significantly concentrated in 
three fractions (CHCl3, EtOAc and alkaloidal, n=3 for each fraction, mean 
± sd) with similar results obtained with the NRU assay. The alkaloidal 
fraction had the maximum effect on the cells. (Fig. 2).
Cell viability
We noticed that Cd treatment in HepG2 cells caused dose-dependent 
growth inhibition. Cytotoxic activity was determined by cell viability. The 
methanolic Cd aerial parts extract decreased the cell viability of HepG2 
cancer cells prominently whereas in HLE the toxicity was quite less.
DISCUSSION
Chemoprevention is a novel approach emphasizing on the prevention 
or delay of carcinogenesis by means of pharmacological, biological, and 
nutritional intervention and recently, cancer chemoprevention with 
strategies using foods and medicinal herbs has been regarded as one of 
the most visible fields for cancer control [29].
Palliative treatments for HCC are indicated if there is no curative treatment 
option, four palliative treatments are transarterial chemo-embolization, 
systemic chemotherapy, interferon, and hormonotherapy [30]. However, 
Fig. 1: Cytotoxicity activity of a methanolic crude extract of Corchorus 
depressus using MTT and neutral red uptake assay with apparent 
IC50 about 200 µg/mL after 24 h of treatment ± standard deviation
Fig. 2: Cytotoxic activity of fractions (200 µg/mL) from Corchorus 
depressus methanolic extract using MTT and NRU assay indicating 
the most potent fraction after 24 h treatment
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palliative therapy of patients with HCC remains challenging as HCC is 
highly resistant to systemic therapies. More importantly, the incidence 
still nearly equals the mortality rate and more than 80% of patients 
present with advanced disease [31]. The overall disappointing results 
of both curative therapies and palliative treatments in advanced 
HCC patients support the research for other more active and specific 
treatments to be administered alone or in combination with the current 
therapy. Herbal compounds could affect all phases of HCC, including 
initiation, promotion, and progression [32]. The active development 
of innovative therapeutic approaches and molecularly targeted agents 
using herbal medicine could offer an opportunity to study the agents in 
HCC and gives new hope for the future.
In vitro cytotoxicity studies are commonly performed to evaluate 
the anticancer potentials of a drug or plant extracts. In this study, we 
noticed the cytotoxic potential of Cd in human liver cancer cell line.
Some of the mutagenic and carcinogenic effects of various carboline 
alkaloids have been related to their ability to intercalate into 
DNA [33,34] leading to altered DNA replication fidelity and enzymatic 
activities in DNA-repair processes [35,36]. They also significantly reduce 
cell proliferation [37]. In human neuroblastoma SH-SY5Y cells, some 
carboline alkaloids induced apoptosis as well as necrosis. Phytochemical 
evaluation of Cd has indicated the presence of β-carboline alkaloid/s so 
probably this cytotoxic effect of cd may be by above-cited mechanism.
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